The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target

被引：37

作者：

Vafaei, Somayeh ^{[1
]}

Taheri, Hamed ^{[2
,3
]}

Hajimomeni, Yasamin ^{[4
]}

Yaseri, Amirhossein Fakhre ^{[5
]}

Zadeh, Firoozeh Abolhasani ^{[6
]}

机构：

[1] Iran Univ Med Sci, Fac Adv Technol Med, Dept Mol Med, Tehran, Iran

[2] Zahedan Univ Med Sci, Res Ctr, Internal Med Cellular & Mol, Zahedan, Iran

[3] Mashhad Univ Med Sci, GI, Zahedan, Iran

[4] Islamic Azad Univ Med Sci, Qeshm Int Branch, Qeshm, Iran

[5] Qazvin Univ Med Sci, Fac Med, Qazvin, Iran

[6] Kerman Univ Med Sci, Fac Med, Dept Surg, Kerman, Iran

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2022年 / 24卷 / 10期

关键词：

Inflammasome; Colorectal cancer; NLRP3; Inflammation; Cancer therapy; EPITHELIAL-MESENCHYMAL TRANSITION; ARYL-HYDROCARBON RECEPTOR; ENVIRONMENTAL-FACTORS; COLON; TUMORIGENESIS; ACTIVATION; COLITIS; SUSCEPTIBILITY; MACROPHAGES; METASTASIS;

D O I：

10.1007/s12094-022-02861-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

All phases of carcinogenesis are affected by inflammation. Activation of the inflammasome is a crucial signaling mechanism that leads to acute and chronic inflammation. When specific nucleotide-binding domains, leucine-rich repeat-containing proteins (NLRs) are activated, inflammasomes are formed. The NLRP3 is one of the NLR family members with the most functional characterization. NLRP3 can modulate the immune systems, apoptosis, growth, and/or the gut microbiome to impact cancer development. Colorectal cancer (CRC) is one of the most common cancers, and it begins as a tissue overgrowth on the internal part of the rectum or colon. In vivo and in vitro studies showed that the NLRP3 inflammasome has a role in CRC development due to its broad activity in shaping immune responses. Here, onwards, we focus on the NLRP3 inflammasome role in CRC development, as well as the therapeutic prospective of modifying NLRP3 inflammasome in the context of anti-cancer therapy.

引用

页码：1881 / 1889

页数：9

共 77 条

[1] The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer [J].

Allen, Irving C. ;

TeKippe, Erin McElvania ;

Woodford, Rita-Marie T. ;

Uronis, Joshua M. ;

Holl, Eda K. ;

Rogers, Arlin B. ;

Herfarth, Hans H. ;

Jobin, Christian ;

Ting, Jenny P. -Y. .

JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (05) :1045-1056

[2] Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis [J].

Azadeh, Hossein ;

Alizadeh-Navaei, Reza ;

Rezaiemanesh, Alireza ;

Rajabinejad, Misagh .

INFLAMMOPHARMACOLOGY, 2022, 30 (02) :435-451

[3] Epidemiological transition of colorectal cancer in developing countries: Environmental factors, molecular pathways, and opportunities for prevention [J].

Bishehsari, Faraz ;

Mahdavinia, Mahboobeh ;

Vacca, Michele ;

Malekzadeh, Reza ;

Mariani-Costantini, Renato .

WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (20) :6055-6072

[4] LOCALIZATION OF THE GENE FOR FAMILIAL ADENOMATOUS POLYPOSIS ON CHROMOSOME-5 [J].

BODMER, WF ;

BAILEY, CJ ;

BODMER, J ;

BUSSEY, HJR ;

ELLIS, A ;

GORMAN, P ;

LUCIBELLO, FC ;

MURDAY, VA ;

RIDER, SH ;

SCAMBLER, P ;

SHEER, D ;

SOLOMON, E ;

SPURR, NK .

NATURE, 1987, 328 (6131) :614-616

[5] RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis [J].

Brunker, Peter ;

Wartha, Katharina ;

Friess, Thomas ;

Grau-Richards, Sandra ;

Waldhauer, Inja ;

Koller, Claudia Ferrara ;

Weiser, Barbara ;

Majety, Meher ;

Runza, Valeria ;

Niu, Huifeng ;

Packman, Kathryn ;

Feng, Ningping ;

Daouti, Sherif ;

Hosse, Ralf J. ;

Mossner, Ekkehard ;

Weber, Thomas G. ;

Herting, Frank ;

Scheuer, Werner ;

Sade, Hadassah ;

Shao, Cuiying ;

Liu, Bin ;

Wang, Peng ;

Xu, Gary ;

Vega-Harring, Suzana ;

Klein, Christian ;

Bosslet, Klaus ;

Umana, Pablo .

MOLECULAR CANCER THERAPEUTICS, 2016, 15 (05) :946-957

[6] Pretreatment with a Heat-Killed Probiotic Modulates the NLRP3 Inflammasome and Attenuates Colitis-Associated Colorectal Cancer in Mice [J].

Chung, I-Che ;

OuYang, Chun-Nan ;

Yuan, Sheng-Ning ;

Lin, Hsin-Chung ;

Huang, Kuo-Yang ;

Wu, Pao-Shu ;

Liu, Chia-Yuan ;

Tsai, Kuen-Jou ;

Loi, Lai-Keng ;

Chen, Yu-Jen ;

Chung, An-Ko ;

Ojcius, David M. ;

Chang, Yu-Sun ;

Chen, Lih-Chyang .

NUTRIENTS, 2019, 11 (03)

[7] Emerging Significance of NLRs in Inflammatory Bowel Disease [J].

Davis, Beckley K. ;

Philipson, Casandra ;

Hontecillas, Raquel ;

Eden, Kristin ;

Bassaganya-Riera, Josep ;

Allen, Irving C. .

INFLAMMATORY BOWEL DISEASES, 2014, 20 (12) :2412-2432

[8] Genetic predisposition to colorectal cancer [J].

de la Chapelle, A .

NATURE REVIEWS CANCER, 2004, 4 (10) :769-780

[9] Paradoxical roles of the immune system during cancer development [J].

de Visser, KE ;

Eichten, A ;

Coussens, LM .

NATURE REVIEWS CANCER, 2006, 6 (01) :24-37

[10] NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver [J].

Deng, Qiaoting ;

Geng, Yan ;

Zhao, Liying ;

Li, Ru ;

Zhang, Zhigao ;

Li, Kun ;

Liang, Rongliang ;

Shao, Xiangyang ;

Huang, Maoliang ;

Zuo, Daming ;

Wu, Yingsong ;

Ma, Qiang .

CANCER LETTERS, 2019, 442 :21-30

← 1 2 3 4 5 6 7 8 →